Comparative Transcriptome Analysis Identifies Desmoglein-3 as a Potential Oncogene in Oral Cancer Cells

Comparative Transcriptome Analysis Identifies Desmoglein-3 as a Potential Oncogene in Oral Cancer Cells

The role of desmoglein-3 (DSG3) in oncogenesis is unclear. This study aimed to uncover molecular mechanisms through comparative transcriptome analysis in oral cancer cells, defining potential key genes and associated biological processes related to DSG3 expression. Four mRNA libraries of oral squamo...

Full description

Bibliographic Details
Main Authors:	Hong Wan, Muy-Teck Teh, Giulia Mastroianni, Usama Sharif Ahmad
Format:	Article
Language:	English
Published:	MDPI AG 2023-11-01
Series:	Cells
Subjects:	desmoglein-3 oral squamous carcinoma cells RNA-Seq bioinformatics transmission electron microscopy desmosomes
Online Access:	https://www.mdpi.com/2073-4409/12/23/2710

Similar Items

Evaluation of desmoglein 1 and desmoglein 3 autoantibodies in oral cancer: A pilot study
by: Pavan Kumar Yellarthi, et al.
Published: (2023-01-01)

Pemphigus Vulgaris: Application of Occlusal Soft Splint with Topical Steroid in the Treatment
by: G Vivekanandh Reddy, et al.
Published: (2011-01-01)

Keratinocyte Binding Assay Identifies Anti-Desmosomal Pemphigus Antibodies Where Other Tests Are Negative
by: Federica Giurdanella, et al.
Published: (2018-04-01)

Desmoglein 3: A Help or a Hindrance in Cancer Progression?
by: Louise Brown, et al.
Published: (2015-01-01)

YAP Inhibition by Verteporfin Causes Downregulation of Desmosomal Genes and Proteins Leading to the Disintegration of Intercellular Junctions
by: Yunying Huang, et al.
Published: (2022-05-01)

Electron microscopy of desmosomal structures in the pemphigus human skin organ culture model
by: Uta Katharina Radine, et al.
Published: (2022-11-01)

Dsg1 and Dsg3 Composition of Desmosomes Across Human Epidermis and Alterations in Pemphigus Vulgaris Patient Skin
by: Thomas Schmitt, et al.
Published: (2022-05-01)

Cortical tension regulates desmosomal morphogenesis
by: Marcin Moch, et al.
Published: (2022-10-01)

Desmoglein‐3 induces YAP phosphorylation and inactivation during collective migration of oral carcinoma cells
by: Usama Sharif Ahmad, et al.
Published: (2022-04-01)

Squamous cell carcinoma of the soft palate associated with autoantibodies to desmoglein 1 and 3
by: Yoshifumi Maumi, et al.
Published: (2013-10-01)

E-cadherin binds to desmoglein to facilitate desmosome assembly
by: Omer Shafraz, et al.
Published: (2018-07-01)

Treatment-naïve pemphigus patients showing IgG tissue deposits have serum IgG antibodies against desmoglein 1 detected more often than those against desmoglein 3: a monocentre laboratory experience
by: Magdalena Jałowska, et al.
Published: (2023-06-01)

Molecular insight into arrhythmogenic cardiomyopathy caused by DSG2 mutations
by: Baowei Zhang, et al.
Published: (2023-11-01)

A Novel In Vivo Active Pemphigus Model Targeting Desmoglein1 and Desmoglein3: A Tool Representing All Pemphigus Variants
by: Roberta Lotti, et al.
Published: (2023-05-01)

Psychosocial Stress Hastens Disease Progression and Sudden Death in Mice with Arrhythmogenic Cardiomyopathy
by: Jacopo Agrimi, et al.
Published: (2020-11-01)

The Desmosomal Cadherin Desmoglein-2 Experiences Mechanical Tension as Demonstrated by a FRET-Based Tension Biosensor Expressed in Living Cells
by: Sindora R. Baddam, et al.
Published: (2018-06-01)

Reactivation of PPARα alleviates myocardial lipid accumulation and cardiac dysfunction by improving fatty acid β-oxidation in Dsg2-deficient arrhythmogenic cardiomyopathy
by: Yubi Lin, et al.
Published: (2023-01-01)

Binding Mechanism Elucidation of the Acute Respiratory Disease Causing Agent Adenovirus of Serotype 7 to Desmoglein-2
by: Marc-André Hograindleur, et al.
Published: (2020-09-01)

Atomic Force Microscopy Provides New Mechanistic Insights into the Pathogenesis of Pemphigus
by: Franziska Vielmuth, et al.
Published: (2018-03-01)

Whole-exome sequencing identified a novel desmoglein-2 gene mutation associated with familial arrhythmogenic right ventricular cardiomyopathy
by: Nianwei Zhou, et al.
Published: (2017-01-01)

Tacrolimus reverses pemphigus vulgaris serum-induced depletion of desmoglein in HaCaT cells via inhibition of heat shock protein 27 phosphorylation
by: Zhimin Xie, et al.
Published: (2023-11-01)

The prognostic and clinicopathological significance of desmoglein 2 in human cancers: a systematic review and meta-analysis
by: Jiantao Wang, et al.
Published: (2022-03-01)

Desmoglein-2 as a cancer modulator: friend or foe?
by: Kay K. Myo Min, et al.
Published: (2023-12-01)

Evaluation of the possible association between acantholysis and anti‐desmogleins 1 and 3 values in pemphigus vulgaris and pemphigus foliaceus
by: Maryam Mobarakabadi, et al.
Published: (2019-12-01)

HLA class II antigens in Croatian patients with pemphigus vulgaris and their correlation with anti-desmoglein antibodies
by: Ines Lakoš Jukić, et al.
Published: (2023-07-01)

Pemphigus Foliaceus Autoantibodies Induce Redistribution Primarily of Extradesmosomal Desmoglein 1 in the Cell Membrane
by: Matthias Hiermaier, et al.
Published: (2022-05-01)

The Double Mutation <i>DSG2</i>-p.S363X and <i>TBX20</i>-p.D278X Is Associated with Left Ventricular Non-Compaction Cardiomyopathy: Case Report
by: Roman Myasnikov, et al.
Published: (2021-06-01)

Co-Expression of Coxsackievirus/Adenovirus Receptors and Desmoglein 2 in Lung Adenocarcinoma: A Comprehensive Analysis of Bioinformatics and Tissue Microarrays
by: Ching-Fu Weng, et al.
Published: (2020-11-01)

Hemi- and Homozygous Loss-of-Function Mutations in DSG2 (Desmoglein-2) Cause Recessive Arrhythmogenic Cardiomyopathy with an Early Onset
by: Andreas Brodehl, et al.
Published: (2021-04-01)

Ultrastructural skin alterations of healthy subjects with anti-desmoglein 1 antibodies in endemic areas to pemphigus foliaceus: A case series
by: Willy Ramos, et al.
Published: (2023-12-01)

Evolving Mechanisms in the Pathophysiology of Pemphigus Vulgaris: A Review Emphasizing the Role of Desmoglein 3 in Regulating p53 and the Yes-Associated Protein
by: Ambreen Rehman, et al.
Published: (2021-06-01)

Immunocytometric Analysis of Oral Pemphigus vulgaris Patients after Treatment with Rituximab as Adjuvant
by: Giulio Fortuna, et al.
Published: (2021-11-01)

Anti-Thyroid Peroxidase Reactivity Is Heightened in Pemphigus Vulgaris and Is Driven by Human Leukocyte Antigen Status and the Absence of Desmoglein Reactivity
by: Kristina Seiffert-Sinha, et al.
Published: (2018-04-01)

Potential correlation of oral flora with pemphigus vulgaris – A case control study
by: Bing-jie Li, et al.
Published: (2023-10-01)

Paradoxical Roles of Desmosomal Components in Head and Neck Cancer
by: Yin-Qiao Liu, et al.
Published: (2021-06-01)

Altered Electrical, Biomolecular, and Immunologic Phenotypes in a Novel Patient-Derived Stem Cell Model of Desmoglein-2 Mutant ARVC
by: Robert N. Hawthorne, et al.
Published: (2021-07-01)

A 3-mRNA-based prognostic signature of survival in oral squamous cell carcinoma
by: Ruoyan Cao, et al.
Published: (2019-07-01)

Construction of the miRNA-mRNA regulatory network and analysis of hub genes in oral squamous cell carcinoma
by: Zifeng Cui, et al.
Published: (2022-09-01)

Efficacy of combination therapy of steroid and methotrexate for refractory pemphigus
by: Miwa Kanaoka, et al.
Published: (2021-10-01)

Taiwanese dermatological association (TDA) consensus for the management of pemphigus
by: Chia-Yu Chu, et al.
Published: (2023-07-01)